AH

Alokkumar Himatlal Pandya

Active Director Designated Partner DIN 10012267
DIN 10012267 First appointment Jul 2022 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Alokkumar Himatlal Pandya

Data last updated:

Alokkumar Himatlal Pandya is a Designated Partner at Narayan Pharma House Llp (since 2022). The company operates in Home Appliances.

DIN 10012267
Primary Designation Designated Partner
Industry Home Appliances
First Appointment 21 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jul 20222022Active

Board colleagues of Alokkumar Himatlal Pandya

Directorship timeline

Open interactive timeline →
Narayan Pharma House Llp
Premium access

Shareholding and investment profile for Alokkumar Himatlal Pandya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alokkumar Himatlal Pandya

Alokkumar Himatlal Pandya currently holds 1 directorship: Narayan Pharma House Llp (Designated Partner, since 21 Jul 2022).

Alokkumar Himatlal Pandya was first appointed on 21 Jul 2022 as Designated Partner at Narayan Pharma House Llp.

The current boards of Alokkumar Himatlal Pandya's companies include Chetanbhai Rugnathbhai Matholiya (Narayan Pharma House Llp), Jayeshbhai Amarashibhai Sabava (Narayan Pharma House Llp), Rahulbhai Oghadbhai Suliya (Narayan Pharma House Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available